S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:NXTC

NextCure Earnings Date, Estimates & History

$11.54
-0.02 (-0.17 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.13
Now: $11.54▼
$11.69
50-Day Range
$11.33
MA: $12.60▼
$13.88
52-Week Range
$7.91
Now: $11.54▼
$44.71
Volume125,637 shs
Average Volume255,267 shs
Market Capitalization$317.96 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.4

Earnings

NextCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 11th, 2021 based off prior year's report dates.

NextCure Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NextCure (NASDAQ:NXTC) Earnings Estimates

2021 EPS Consensus Estimate: ($2.40)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.61)($0.41)($0.51)
Q2 20212($0.66)($0.46)($0.56)
Q3 20212($0.69)($0.48)($0.59)
Q4 20211($0.74)($0.74)($0.74)
Q1 20221($0.72)($0.72)($0.72)
Q2 20221($0.77)($0.77)($0.77)
Q3 20221($0.82)($0.82)($0.82)

NextCure (NASDAQ NXTC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/11/2021
(Estimated)		       
11/5/20209/30/2020($0.57)($0.59)($0.59)Listen
8/6/20206/30/2020($0.50)($0.53)($0.53)N/A
5/7/20203/31/2020($0.44)$0.33$0.33$1.30 million$22.38 millionN/A
3/12/2020Q4 2019($0.33)($0.34)($0.34)$1.48 million$2.01 millionN/A
11/12/2019Q3($0.35)($0.37)($0.37)$1.50 million$1.58 millionN/A
8/12/2019Q2 2019($0.4650)($0.61)($0.61)$1.50 million$1.40 millionN/A
6/10/2019Q1 2019($0.53)($4.46)($4.46)$1.36 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/3/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.